Does GEMCITABINE Cause Bladder transitional cell carcinoma? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Bladder transitional cell carcinoma have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.0% of all adverse event reports for GEMCITABINE.
5
Reports of Bladder transitional cell carcinoma with GEMCITABINE
0.0%
of all GEMCITABINE reports
2
Deaths
0
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From GEMCITABINE?
Of the 5 reports, 2 (40.0%) resulted in death.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Malignant neoplasm progression (1,962)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which GEMCITABINE Alternatives Have Lower Bladder transitional cell carcinoma Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN